| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2008 | CN101177433A (s)-ornidazole disodium phosphate pentahydrate as well as preparation method and uses thereof |
| 05/14/2008 | CN101177429A Topoisomerase enzyme inhibitor, preparation method and use thereof |
| 05/14/2008 | CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 05/14/2008 | CN101177426A Process for separating extracting spherosinin from gansu whin |
| 05/14/2008 | CN101177425A Novel epothilones compound as well as preparation method and use thereof |
| 05/14/2008 | CN101177424A High-purity silybin meglumine, preparation method as well as application in preparing medicine treating hepatitis and liver hurt thereof |
| 05/14/2008 | CN101177422A Process for preparing methylation catechin by tea |
| 05/14/2008 | CN101177421A Method for preparing high-purity taxone compounds |
| 05/14/2008 | CN101177415A Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 05/14/2008 | CN101177414A New crystal form of anti-cancer compound ZD1839, preparation method thereof and medical compound containing the crystal form |
| 05/14/2008 | CN101177413A 6-cyclohexyl methyl substituted S-DABO compound, method for synthesizing same and uses thereof |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/14/2008 | CN101176788A Pharmaceutical composition for ACE restrainer/uretica/folic acid, and uses thereof |
| 05/14/2008 | CN101176787A Method for chemoprevention of prostate cancer |
| 05/14/2008 | CN101176786A Method and composition for increasing insulin sensibility |
| 05/14/2008 | CN101176747A Application of motherwort aqueous extract in the preparation of medicament for curing ischemic heart disease |
| 05/14/2008 | CN101176737A Pharmaceutical composition of chicken bile and preparation thereof |
| 05/14/2008 | CN101176735A Composite preparations for curing schemic brain damage |
| 05/14/2008 | CN101176734A Nutrients replenisher for replenishing folic acid and vitamin B12 and preparation method thereof |
| 05/14/2008 | CN101176733A Application of fiber-doffing in the preparation of medicament for curing and/or preventing blood vessel disease |
| 05/14/2008 | CN101176732A Hydrochloric acid glucosamine dispersible tablet and preparation method thereof |
| 05/14/2008 | CN101176731A Application of asiatic acid in the aspect of resisting pulmonary fibrosis |
| 05/14/2008 | CN101176730A Pharmaceutical composition and technique of preparing the same |
| 05/14/2008 | CN101176729A Huperzine dropping pills and preparation method thereof |
| 05/14/2008 | CN101176728A Capsule for preventing and treating fatty liver and preparation method thereof |
| 05/14/2008 | CN101176727A Policosanol soft capsule and preparation method thereof |
| 05/14/2008 | CN101176725A Stabilizer type of simvastatir and aspirin |
| 05/14/2008 | CN101176724A Oxymatrine or matrine sustained-release pellet and preparation method thereof |
| 05/14/2008 | CN101176723A Ranolazine sustained release tablets |
| 05/14/2008 | CN101176722A Scutellaria glycosides freeze dried injection solution and preparation method thereof |
| 05/14/2008 | CN101176721A Hexamethylmelamine liposome and preparation method thereof |
| 05/14/2008 | CN101176720A Ligustrazine microcosmic salt liposome medicine and preparing method |
| 05/14/2008 | CN101176719A Paclitaxel/multialkene paclitaxel liposome composite medicine and preparation method thereof |
| 05/14/2008 | CN101176718A Netilmicin liposome and technique of preparing the same |
| 05/14/2008 | CN101176716A Sunitinib sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176715A Gefitinib sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176714A Meifaron sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176713A Carmustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176712A Nimustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176711A Yitarbisin sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176710A Mitoxantrone sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176709A Beisalutin sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176708A Carmofur sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176707A Carmustine sustained-release implantation agent for curing entity tumour |
| 05/14/2008 | CN101176698A Product and method for eliminating oral cavity bitter |
| 05/14/2008 | CN100387706C Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
| 05/14/2008 | CN100387703C Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387609C Novel antibiotic preparing process |
| 05/14/2008 | CN100387603C Eremophil dilactone natural product with tumour cell growth inhibiting activity |
| 05/14/2008 | CN100387602C Chelerythrine compound and its preparing method |
| 05/14/2008 | CN100387600C N-substituted hydromorphones and the use thereof |
| 05/14/2008 | CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387596C Preparation of 13-hexyl berberine salt and its anti-virus and antibacterial action |
| 05/14/2008 | CN100387594C Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 05/14/2008 | CN100387589C Flavanone compound and uses thereof |
| 05/14/2008 | CN100387585C Tanshinone I derivatives and pharmaceutical application thereof |
| 05/14/2008 | CN100387580C Tricyclic triazolobenzazepine, derivatives, process for producing the same, and antiallergic |
| 05/14/2008 | CN100387296C New dialysis method |
| 05/14/2008 | CN100387295C Wanhua oil Babu plaster for traumatic injury and preparing method |
| 05/14/2008 | CN100387277C Preparation method of notoginseng-containing tablet for treating traumatic injury |
| 05/14/2008 | CN100387262C Hedyotis herba powder injection |
| 05/14/2008 | CN100387261C Medicnial liquid and technology for one step removing freckle, chloasma and senile plague |
| 05/14/2008 | CN100387260C Eye medicine for treating senile cataract and its pH value regulating method and preparing process thereof |
| 05/14/2008 | CN100387238C Medical hemostasis anti-adhesive irrigation solution |
| 05/14/2008 | CN100387237C Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
| 05/14/2008 | CN100387236C Pharmacetutical for treating cardiovascular and cerebrovascular disease and its preparing process |
| 05/14/2008 | CN100387235C New pharmaceutical use of echinacoside |
| 05/14/2008 | CN100387234C Medicine containing forrest silk vine root orherb aglycone, and its preparing method and use |
| 05/14/2008 | CN100387233C Use of levo morpholine nidazole for preparing medicine for antiparasitic infection |
| 05/14/2008 | CN100387232C Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone in preparing medicine |
| 05/14/2008 | CN100387231C Process for preparing colatemo solid preparation and its solid preparation |
| 05/14/2008 | CN100387230C Pharmaceutical combination prepared by cannabis extract |
| 05/14/2008 | CN100387229C Amiodarone hydro chloride dispensible tablet, and its preparing method |
| 05/14/2008 | CN100387228C Injectable methadone, partial opioid-opium agonist or opioid-opium antagonist particle composition, and use thereof |
| 05/14/2008 | CN100387226C Cepharanthine oral disintegration tablet and its preparing method |
| 05/14/2008 | CN100387222C Solid preparation for dialysis and process for producing the same |
| 05/14/2008 | CN100387220C Preparation for eyes and preparing method thereof |
| 05/14/2008 | CN100387219C Pharmaceutical and cosmetic compositions against skin aging |
| 05/14/2008 | CN100387218C Immune globulin G biological factor oral detergent |
| 05/14/2008 | CN100387153C Method for preparing blood sugar-decreasing, stomach-benefiting, health-preserving soybean yoghurt with micron holoside, ginseng, solomonseal, chlorophyll, propolis and chromium powder |
| 05/14/2008 | CN100387140C Method for preparing compound micrometer radix pseudostellariae sugar reducing and calcium supplementing milk tablet |
| 05/14/2008 | CN100387139C Method for preparing compound micrometer radix pseudostellariae sugar reducing and calcium supplementing bean milk tablet |
| 05/14/2008 | CN100387138C Method for preparing compound micrometer radix pseudostellariae sugar reducing and calcium supplementing milk powder |
| 05/14/2008 | CN100387135C Method for preparing compound micrometer radix pseudostellariae sugar reducing and calcium supplementing milk |
| 05/14/2008 | CA2610613A1 Antimicrobial compositions |
| 05/13/2008 | US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371888 α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
| 05/13/2008 | US7371875 Compounds based on 3,7-dioxo-2-aza-6-oxabicyclo(3.2.0)heptane; proteosome inhibitors for treating proliferative or inflammatory disorders with better stability, toxicity and/or oral bioavailability |
| 05/13/2008 | US7371874 5-lipoxygenase inhibitor, leukotriene antagonist; rheumatoid arthritis, colitis, asthma, psoriasis; coupling 6-amino-2-methyl-2'methyl(aminoprtotecting)-2H-7,8-disubstituted benzopyran with backbone amide linker, coupling with radical to N atom; deprotection, sulfonation, cleavage with a dichloromethane |
| 05/13/2008 | US7371872 (1R,4S,5S,6S)-4-(2'S-4'-methylthio-2'-aminobutanonyl)amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid; nervous system, psychological, and psychiatric disorders |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371869 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders |
| 05/13/2008 | US7371868 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane. |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371860 PNA monomer and precursor |
| 05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
| 05/13/2008 | US7371855 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |